Supporting Stroke Awareness: Moleac at Changi General Hospital’s Inaugural Stroke Matters Day
Stroke Matters at Changi General Hospital – Singapore
Engaging Discussions at the V National Congress of Neurology in Panama: Highlights from Moleac’s NeuroAiD Symposium
Together with Droguería Saro, Moleac was honored to participate in the V National Congress of Neurology, held in Panama in October.
World Stroke Day: Moleac’s Commitment to Helping Stroke Patients Reconnect with Their Lives
Today is World Stroke Day! Every year on October 29th, World Stroke Day is a great opportunity to raise awareness on stroke.
Join the Upcoming ASAP Webinar on Direct Oral Anticoagulants – Supported by Moleac
Moleac is delighted to support the upcoming webinar on Direct Orals Anticoagulants hosted by the Asian Stroke Advisory Panel (ASAP) gathering neurology experts from Asia.
Reflecting on the NeuroAiD Dinner Symposium: Insights into Advancing Neurological Care at WSC 2024 in Abu Dhabi
Thank you for joining us at the NeuroAiD Dinner Symposium alongside the World Stroke Congress 2024 in Abu Dhabi.
Visit Moleac at Booth 14: Explore Innovative Stroke Solutions at the World Stroke Congress in Abu Dhabi
We are at the World Stroke Congress (WSC) in Abu Dhabi!
Stepping Out for Stroke 2024: Moleac Joins SNSA Walkathon to Promote Stroke Prevention and Awareness
Moleac team was delighted to be part of the Stepping Out for Stroke 2024 walkathon, hosted by the Singapore National Stroke Association (SNSA).
📢 Moleac Announces PT Ferron Par Pharmaceuticals as New Exclusive Partner in Indonesia
Moleac is excited to announce a significant milestone in the journey of NeuroAiD II MLC901 as PT Ferron Par Pharmaceuticals will become our exclusive partner in Indonesia effective Jan 1ˢᵗ 2025.
Join Us at the World Stroke Congress 2024 in Abu Dhabi – Visit Us at Booth 14!
We are thrilled to announce our participation at the World Stroke Congress (WSC) from October 23ʳᵈ to 26ᵗʰ, 2024, in Abu Dhabi.